- Tytuł:
- Treatment with a Cholecystokinin Receptor Antagonist, Proglumide, Improves Efficacy of Immune Checkpoint Antibodies in Hepatocellular Carcinoma.
- Autorzy:
- Źródło:
- International Journal of Molecular Sciences. Feb2023, Vol. 24 Issue 4, p3625. 16p.
Czasopismo naukowe